All CAR-expressing T cells also had increased glycolysis above that of unmodified T cells, which suggests that the IL7R pathway–activated T cells may have improved and effective antitumor activity in the metabolically unfavorable leukemia microenvironment. This evidence concerns the gene IL7R and leukemia.